Crimmins Darach William, Pierre-Kahn Alain, Sainte-Rose Christian, Zerah Michel
Department of Pediatric Neurosurgery, Hôpital Necker-Enfants Malades, Paris, France.
J Neurosurg. 2006 Aug;105(2 Suppl):107-14. doi: 10.3171/ped.2006.105.2.107.
The authors sought to determine the natural history of and optimal treatment for suprasellar cysts (SSCs).
Three hundred forty-two patients harboring intracranial cysts presented to the authors' neurosurgery unit between January 1986 and August 2004. The patients' records were reviewed to assess symptomatology, results of imaging studies, and outcome according to mode of treatment. Thirty-three patients (9.6%) were eligible for this study. Nine SSCs were diagnosed prenatally and 24 were identified postnatally (range 0 months-18.2 years, mean 5.6 years). The mean follow-up period was 66.8 +/- 44.6 months (standard deviation). Seven cysts were left untreated, six (66%) detected before birth and one (4.5%) after birth. Of the 26 patients who required surgery, three were admitted elsewhere for complications of shunt surgery. A ventriculocystostomy (VC) was performed in all three of these patients, but the treatment failed in two. The primary treatment in the remaining 23 children was: open fenestration in two patients, VC in seven, ventriculocystocisternostomy (VCC) in 13, and cystoperitoneal (CP) shunt in one patient. Both open fenestration procedures were successful, as was the CP shunt insertion. The success rate of primary endoscopic surgery, although not statistically significant, was higher for VCCs (11 [85%] of 13 patients) than for VCs (four [57%] of seven patients). None of the patients' preoperative endocrine disorders resolved postoperatively. The distribution of intellectual and developmental quotients paralleled the normal range. Intellectual performance was unrelated to patient-specific factors or to treatment modalities.
Most SSCs are of moderate size, are stable and asymptomatic, and have a favorable outcome. Treatment is required when the cyst evolves or the patient is symptomatic, but endocrine disturbances alone are not an indication for surgery. When hydrocephalus is present, endoscopic fenestration is the primary treatment of choice. The goal of the procedure should be to open the cyst into both the ventricles and the cisterns. Intellectual capability after treatment at outcome is not related to age at diagnosis, initial or final cyst size, presence or absence of hydrocephalus, or type of endoscopic treatment.
作者试图确定鞍上囊肿(SSCs)的自然病程及最佳治疗方法。
1986年1月至2004年8月期间,342例颅内囊肿患者到作者所在的神经外科就诊。回顾患者的病历,根据治疗方式评估症状、影像学检查结果及预后。33例患者(9.6%)符合本研究条件。9例SSCs在产前被诊断出,24例在产后被发现(范围0个月至18.2岁,平均5.6岁)。平均随访期为66.8±44.6个月(标准差)。7个囊肿未接受治疗,6个(66%)在出生前被发现,1个(4.5%)在出生后被发现。在需要手术的26例患者中,3例因分流手术并发症在其他地方就诊。这3例患者均接受了脑室囊肿造瘘术(VC),但2例治疗失败。其余23例儿童的主要治疗方法为:2例行开放造瘘术,7例行VC,13例行脑室囊肿脑池造瘘术(VCC),1例行囊肿-腹腔(CP)分流术。2例开放造瘘术均成功,CP分流术置入也成功。尽管无统计学意义,但VCCs的初次内镜手术成功率(13例患者中的11例[85%])高于VCs(7例患者中的4例[57%])。患者术前的内分泌紊乱术后均未缓解。智力和发育商数的分布与正常范围相符。智力表现与患者个体因素或治疗方式无关。
大多数SSCs体积中等,稳定且无症状,预后良好。当囊肿进展或患者出现症状时需要治疗,但仅内分泌紊乱并非手术指征。当存在脑积水时,内镜下造瘘是主要的治疗选择。手术的目标应是将囊肿与脑室和脑池均打通。治疗后的智力水平与诊断时的年龄、初始或最终囊肿大小、是否存在脑积水或内镜治疗类型无关。